QIAN, YIMIN,CREW, ANDREW P.,DONG, HANQING,WANG, JING,CREWS, CRAIG M.
申请号：
CA3087528
公开号：
CA3087528A1
申请日:
2017.09.15
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present disclosure relates to compounds and a pharmaceutically acceptable salt thereof, compositions, combinations and medicaments containing the compounds, and processes for their preparation. The disclosure also relates to the use of the compounds, combinations, compositions and medicaments, for example as inhibitors of the activity of the estrogen receptor, including degrading the estrogen receptor, the treatment of diseases and conditions mediated by the estrogen receptor.
